|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
98 a.a.
|
 |
|
|
|
|
|
|
|
196 a.a.
|
 |
|
|
|
|
|
|
|
179 a.a.
|
 |
|
|
|
|
|
|
|
193 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/signaling protein
|
 |
|
Title:
|
 |
Crystal structure of vegf-c in complex with domains 2 and 3 of vegfr2
|
|
Structure:
|
 |
Vascular endothelial growth factor c. Chain: a, b, c, d. Fragment: vegf homology domain, residues 112-215. Synonym: vegf-c, vascular endothelial growth factor-related protein, vrp, flt4 ligand, flt4-l. Engineered: yes. Mutation: yes. Vascular endothelial growth factor receptor 2. Chain: l, m, n, o.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.230
|
R-free:
|
0.280
|
|
|
Authors:
|
 |
V.M.Leppanen,A.E.Prota,M.Jeltsch,A.Anisimov,N.Kalkkinen,T.Strandin, H.Lankinen,A.Goldman,K.Ballmer-Hofer,K.Alitalo
|
Key ref:
|
 |
V.M.Leppänen
et al.
(2010).
Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Proc Natl Acad Sci U S A,
107,
2425-2430.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Jan-10
|
Release date:
|
09-Mar-10
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P49767
(VEGFC_HUMAN) -
Vascular endothelial growth factor C from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
419 a.a.
98 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P35968
(VGFR2_HUMAN) -
Vascular endothelial growth factor receptor 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1356 a.a.
196 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, M, N, O:
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = )
matches with 41.38% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
107:2425-2430
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural determinants of growth factor binding and specificity by VEGF receptor 2.
|
|
V.M.Leppänen,
A.E.Prota,
M.Jeltsch,
A.Anisimov,
N.Kalkkinen,
T.Strandin,
H.Lankinen,
A.Goldman,
K.Ballmer-Hofer,
K.Alitalo.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel
formation through activation of three receptor tyrosine kinases, VEGFR-1, -2,
and -3. The extracellular domain of VEGF receptors consists of seven
immunoglobulin homology domains, which, upon ligand binding, promote receptor
dimerization. Dimerization initiates transmembrane signaling, which activates
the intracellular tyrosine kinase domain of the receptor. VEGF-C stimulates
lymphangiogenesis and contributes to pathological angiogenesis via VEGFR-3.
However, proteolytically processed VEGF-C also stimulates VEGFR-2, the
predominant transducer of signals required for physiological and pathological
angiogenesis. Here we present the crystal structure of VEGF-C bound to the
VEGFR-2 high-affinity-binding site, which consists of immunoglobulin homology
domains D2 and D3. This structure reveals a symmetrical 22 complex, in which
left-handed twisted receptor domains wrap around the 2-fold axis of VEGF-C. In
the VEGFs, receptor specificity is determined by an N-terminal alpha helix and
three peptide loops. Our structure shows that two of these loops in VEGF-C bind
to VEGFR-2 subdomains D2 and D3, while one interacts primarily with D3.
Additionally, the N-terminal helix of VEGF-C interacts with D2, and the groove
separating the two VEGF-C monomers binds to the D2/D3 linker. VEGF-C, unlike
VEGF-A, does not bind VEGFR-1. We therefore created VEGFR-1/VEGFR-2 chimeric
proteins to further study receptor specificity. This biochemical analysis,
together with our structural data, defined VEGFR-2 residues critical for the
binding of VEGF-A and VEGF-C. Our results provide significant insights into the
structural features that determine the high affinity and specificity of
VEGF/VEGFR interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Structure of the VEGF-C/VEGFR-2D23 complex in a cartoon
representation. The VEGF-C homodimer is shown in orange and
green, and the two VEGFR-2 receptor chains are colored in light
blue. The sugar moieties and the disulfide bonds are shown in
purple and yellow sticks, respectively. VEGF-C binds to the
VEGFR-2 interface between domains 2 and 3.
|
 |
Figure 2.
Interface between VEGF-C and VEGFR-2. (A) VEGF-C binding
interface on VEGFR-2. VEGFR-2 is shown as a cartoon
representation with the VEGF-C binding key residues highlighted
in sticks and labeled. (B) An overview of the VEGF-C/VEGFR-2D23
site 1 interface, with VEGF-C monomer A colored in green and
VEGF-C residues at the interface labeled. VEGFR-2 charge
distribution shown as a surface potential model. (C) The same as
in (B) for the site 2 interface with VEGF-C monomer B in orange
and the monomer 2 key residues labeled. (D) VEGF-C Asp123
interactions with VEGFR-2. Hydrogen bonds and salt bridges are
shown in gray dashed lines. (E) VEGF-C Glu169 interactions with
VEGFR-2 as in (D). (F) VEGF-C Thr148 and Asn149 interactions
with VEGFR-2 as in (D).
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Verstraete,
and
S.N.Savvides
(2012).
Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.
|
| |
Nat Rev Cancer,
12,
753-766.
|
 |
|
|
|
|
 |
F.Boyaud,
and
N.Inguimbert
(2011).
Soluble fms-like tyrosine kinase-1 antibody for diagnosis purposes (WO2010075475).
|
| |
Expert Opin Ther Pat,
21,
971-975.
|
 |
|
|
|
|
 |
V.M.Leppänen,
M.Jeltsch,
A.Anisimov,
D.Tvorogov,
K.Aho,
N.Kalkkinen,
P.Toivanen,
S.Ylä-Herttuala,
K.Ballmer-Hofer,
and
K.Alitalo
(2011).
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.
|
| |
Blood,
117,
1507-1515.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.H.Shim,
H.Liu,
P.J.Focia,
X.Chen,
P.C.Lin,
and
X.He
(2010).
Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.
|
| |
Proc Natl Acad Sci U S A,
107,
11307-11312.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Nilsson,
F.Bahram,
X.Li,
L.Gualandi,
S.Koch,
M.Jarvius,
O.Söderberg,
A.Anisimov,
I.Kholová,
B.Pytowski,
M.Baldwin,
S.Ylä-Herttuala,
K.Alitalo,
J.Kreuger,
and
L.Claesson-Welsh
(2010).
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.
|
| |
EMBO J,
29,
1377-1388.
|
 |
|
|
|
|
 |
M.Rinderknecht,
A.Villa,
K.Ballmer-Hofer,
D.Neri,
and
M.Detmar
(2010).
Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
|
| |
PLoS One,
5,
e11941.
|
 |
|
|
|
|
 |
S.Iyer,
P.I.Darley,
and
K.R.Acharya
(2010).
Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.
|
| |
J Biol Chem,
285,
23779-23789.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |